← Back to Screener
Carlsmed, Inc. Common Stock (CARL)
Price$10.68
Favorite Metrics
Price vs S&P 500 (26W)-24.75%
Price vs S&P 500 (4W)-6.10%
Market Capitalization$292.72M
All Metrics
Book Value / Share (Quarterly)$3.72
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-1.14
Price vs S&P 500 (YTD)-13.98%
Gross Margin (TTM)75.31%
Net Profit Margin (TTM)-58.67%
EPS (TTM)$-1.19
10-Day Avg Trading Volume0.14M
EPS Excl Extra (TTM)$-1.19
EPS (Annual)$-4.17
ROI (Annual)-51.89%
Gross Margin (Annual)75.31%
Cash / Share (Quarterly)$4.13
Revenue Growth QoQ (YoY)-44.17%
ROA (Last FY)-45.55%
EBITD / Share (TTM)$-1.21
Operating Margin (TTM)-60.53%
Cash Flow / Share (Annual)$-2.23
P/B Ratio2.96x
P/B Ratio (Quarterly)3.32x
Net Income / Employee (Annual)$-0
Net Interest Coverage (TTM)-122.11x
ROA (TTM)-31.51%
EPS Incl Extra (Annual)$-4.17
Current Ratio (Annual)8.87x
Quick Ratio (Quarterly)8.49x
3-Month Avg Trading Volume0.12M
Revenue / Employee (TTM)$0
P/S Ratio (Annual)5.80x
Asset Turnover (Annual)0.39x
52-Week High$17.19
EPS Excl Extra (Annual)$-4.17
26-Week Price Return-20.77%
Quick Ratio (Annual)8.49x
13-Week Price Return-24.17%
Total Debt / Equity (Annual)0.16x
Current Ratio (Quarterly)8.87x
Enterprise Value$222.268
Asset Turnover (TTM)0.54x
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-117.34%
Cash / Share (Annual)$4.13
3-Month Return Std Dev75.98%
Net Income / Employee (TTM)$-0
ROE (Last FY)-59.95%
EPS Basic Excl Extra (Annual)$-4.17
Total Debt / Equity (Quarterly)0.16x
EPS Incl Extra (TTM)$-1.19
ROI (TTM)-36.54%
P/S Ratio (TTM)5.80x
Revenue / Share (Annual)$3.55
Year-to-Date Return-11.34%
5-Day Price Return12.65%
EPS Normalized (Annual)$-4.17
Net Profit Margin (Annual)-117.34%
Month-to-Date Return20.99%
EBITD / Share (Annual)$-4.24
Operating Margin (Annual)-121.06%
LT Debt / Equity (Annual)0.16x
LT Debt / Equity (Quarterly)0.16x
EPS Basic Excl Extra (TTM)$-1.19
P/B Ratio (Annual)3.32x
Pretax Margin (TTM)-58.67%
Book Value / Share (Annual)$3.72
Price vs S&P 500 (13W)-24.86%
Beta2.40x
Revenue / Share (TTM)$1.89
ROE (TTM)-45.04%
52-Week Low$8.50
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.27
4.27
4.27
4.27
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
CARLCarlsmed, Inc. Common Stock | 5.80x | — | 75.31% | -60.53% | $10.68 |
SYKStryker Corporation | 5.15x | 11.84% | 64.57% | 19.43% | $338.38 |
BSXBoston Scientific Corp. | 4.76x | 15.16% | 69.01% | 18.00% | $63.42 |
MMM3M Company | 3.18x | -4.97% | 39.92% | 18.55% | $150.55 |
MDLNMedline Inc. Class A common stock | 2.21x | — | 26.44% | 7.78% | $46.94 |
BDXBecton, Dickinson and Co. | 2.01x | 6.32% | 46.42% | 12.15% | $154.82 |
RMDResMed Inc. | 6.06x | 11.72% | 60.85% | 33.70% | $224.72 |
DXCMDexCom, Inc. | 5.23x | 19.33% | 62.09% | 19.56% | $61.23 |
WSTWest Pharmaceutical Services, Inc. | 6.22x | 7.44% | 35.91% | 19.03% | $269.81 |
PODDInsulet Corporation | 5.31x | 24.53% | 71.63% | 12.92% | $201.47 |
PENPenumbra, Inc. | 9.31x | 20.16% | 67.14% | 13.48% | $331.47 |
About
Carlsmed Inc is a commercial-stage medical technology company developing AI-enabled personalized solutions for spine surgery. Its Aprevo platform delivers customized surgical planning and implants for lumbar and cervical fusion procedures, marketed to hospitals and ambulatory surgical centers.